Cost-Effectiveness of Treatment Strategies for Spinal Metastases

Bandini, 2018, Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: A population-based study, Int Urol Nephrol, 50, 71, 10.1007/s11255-017-1744-2 Sundquist, 2017, Improved survival in metastatic breast cancer 1985–2016, Breast, 31, 46, 10.1016/j.breast.2016.10.005 Tharmalingam, 2008, Quality of life measurement in bone metastases: A literature review, J Pain Res, 1, 49 Van den Beuken-van Everdingen, 2007, Prevalence of pain in patients with cancer: A systematic review of the past 40 years, Ann Oncol, 18, 1437, 10.1093/annonc/mdm056 von Moos, 2017, Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain, Eur J Cancer, 71, 80, 10.1016/j.ejca.2016.10.021 Macedo, 2017, Bone metastases: An overview, Oncol Rev, 11, 321 Reyes, 2015, The biology and treatment of oligometastatic cancer, Oncotarget, 6, 8491, 10.18632/oncotarget.3455 Chow, 2014, Single versus multiple fractions of repeat radiation for painful bone metastases: A randomised, controlled, non-inferiority trial, Lancet Oncol, 15, 164, 10.1016/S1470-2045(13)70556-4 Hartsell, 2005, Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases, J Natl Cancer Inst, 97, 798, 10.1093/jnci/dji139 Sahgal, 2021, Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: An open-label, multicentre, randomised, controlled, phase 2/3 trial, Lancet Oncol, 22, 1023, 10.1016/S1470-2045(21)00196-0 Sprave, 2018, Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy, Radiother Oncol, 128, 274, 10.1016/j.radonc.2018.04.030 Levy, 2020, Radiofrequency ablation for the palliative treatment of bone metastases: Outcomes from the multicenter OsteoCool tumor ablation post-market study (OPuS One study) in 100 patients, J Vasc Interv Radiol, 31, 1745, 10.1016/j.jvir.2020.07.014 Chalkidou, 2021, Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: A prospective, registry-based, single-arm, observational, evaluation study, Lancet Oncol, 22, 98, 10.1016/S1470-2045(20)30537-4 Palma, 2019, Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial, Lancet, 393, 2051, 10.1016/S0140-6736(18)32487-5 Sahgal, 2013, Vertebral compression fracture after spine stereotactic body radiotherapy: A multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score, J Clin Oncol, 31, 3426, 10.1200/JCO.2013.50.1411 Husereau, 2013, Consolidated health economic evaluation reporting standards (CHEERS) statement, Int J Technol Assess Health Care, 29, 117, 10.1017/S0266462313000160 Braithwaite, 2008, What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?, Med Care, 349, 10.1097/MLR.0b013e31815c31a7 Briggs, 2002, Probabilistic analysis of cost-effectiveness models: Choosing between treatment strategies for gastroesophageal reflux disease, Medical Decis Making, 22, 290, 10.1177/027298902400448867 Zelefsky, 2021, Phase 3 multi-center, prospective, randomized trial comparing single-dose 24 Gy radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic cancer, Int J Radiat Oncol Biol Phys, 110, 672, 10.1016/j.ijrobp.2021.01.004 Kim, 2015, Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases, Int J Radiat Oncol Biol Phys, 91, 556, 10.1016/j.ijrobp.2014.10.055 Ryu, 2019, Radiosurgery compared to external beam radiotherapy for localized spine metastasis: Phase III results of NRG Oncology/RTOG 0631, Int J Radiat Oncol Biol Phys, 105, S2, 10.1016/j.ijrobp.2019.06.382 Husain, 2017, Stereotactic body radiotherapy for de novo spinal metastases: Systematic review: International Stereotactic Radiosurgery Society practice guidelines, J Neurosurg Spine, 27, 295, 10.3171/2017.1.SPINE16684 Gerszten, 2009, Radiotherapy and radiosurgery for metastatic spine disease: What are the options, indications, and outcomes?, Spine, 34, S78, 10.1097/BRS.0b013e3181b8b6f5 Weichselbaum, 2011, Oligometastases revisited, Nat Rev Clin Oncol, 8, 378, 10.1038/nrclinonc.2011.44 Benson, 2020, Predicting survival for patients with metastatic disease, Int J Radiat Oncol Biol Phys, 106, 52, 10.1016/j.ijrobp.2019.10.032 Balagamwala, 2018, Recursive partitioning analysis is predictive of overall survival for patients undergoing spine stereotactic radiosurgery, J Neurooncol, 137, 289, 10.1007/s11060-017-2716-1 Chao, 2012, Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases, Int J Radiat Oncol Biol Phys, 82, 1738, 10.1016/j.ijrobp.2011.02.019 Jensen, 2017, Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery, J Radiosurg SBRT, 5, 25 Tang, 2015, Creation of a prognostic index for spine metastasis to stratify survival in patients treated with spinal stereotactic radiosurgery: Secondary analysis of mature prospective trials, Int J Radiat Oncol Biol Phys, 93, 118, 10.1016/j.ijrobp.2015.04.050 Huisman, 2012, Effectiveness of reirradiation for painful bone metastases: A systematic review and meta-analysis, Int J Radiat Oncol Biol Phys, 84, 8, 10.1016/j.ijrobp.2011.10.080